Recruiting Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006) NCT06429813 Conditions Behavior, Castrate Sensitive Prostate Cancer, Genital Diseases, +11 more Locations University of Virginia — Charlottesville, Virginia, United States View Trial Details
Recruiting PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer NCT06652607 Conditions Castrate Sensitive Prostate Cancer, Genital Diseases, Genital Diseases, Male, +14 more Locations Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC ONCOLOGIA MEDICA — Rome, Lazio, Italy View Trial Details
Completed Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer NCT03860987 Conditions Castrate Sensitive Prostate Cancer Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Active, Not Recruiting Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) NCT04748042 Conditions Castrate Sensitive Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more Locations University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States View Trial Details
